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ABSTRACT
This article reviews animal models currently used for investigation of ascending genital-tract infec-
tion in pregnancy. The specific models reviewed are those in the rabbit, monkey, and mouse. These
models investigate both the direct effects of bacteria in the setting of ascending infection and the role
of cytokines produced by the immune system. For each model, experiments that delineate the
pathophysiology of ascending genital-tract infection in pregnancy are described. Intervention exper-
iments, including the use of antibiotics, anti-inflammatory agents, immunotherapy, and anti-cyto-
kine therapy, are described. Comparison of these models is made with respect to pathogenesis in
humans, reproducibility, anatomy, and cost. (C) 1994 Wiley-Liss, Inc.
KEy WORS
Intraamniotic infection, preterm labor, bacteria
n spite of concerted efforts over the past 2 decades
to prevent premature delivery and low birth
weight, these problems still represent the leading
cause of perinatal morbidity and mortality in the
United States. Traditionally, the major causes of
preterm birth are categorized as 1) fetal and mater-
nal indications, 2) premature labor, and 3) prema-
ture rupture of the membranes. There is ample
evidence that infection, both clinical and subclini-
cal, may lead to preterm delivery due to either
premature labor or premature rupture of the mem-
branes. High rates of amniotic fluid (AF) infec-
tion, chorioamnionic infection, and histologic
chorioamnionitis have been reported in low birth-
weight deliveries. These rates correlate inversely
with gestational age of delivery. Many microor-
ganisms and certain clinical infections have been
associated with preterm labor, preterm delivery,
and premature rupture of the membranes. Pros-
taglandins, arachidonic-acid metabolites, bacterial
products, and cytokines have all been isolated from
the chorioamnion, decidua or AF in cases of pre-
term birth, especially in those cases accompanied by
infection. While this human evidence does build a
strong case for the role of ascending infection in
pregnancy as a cause of preterm birth, the case is
largely circumstantial. Direct evidence is needed.
Animal models in which variables can be controlled
allow the hypotheses generated from human cases to
be tested in the laboratory.
The purpose of this article is to review the cur-
rent animal models of ascending infection in preg-
nancy. These models investigate the direct effects
of bacteria in the setting of ascending infection, as
well as the role of cytokines which are produced by
the immune system. Particular emphasis will be
given to the rabbit, monkey, and mouse models
under current investigation.
RABBIT MODEL
The rabbit has long been a model for bacterial
infection. Advantages to this species have included
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Polyethylene cannula
Fig. I. Schematic representation of experimental inoculation of rabbit uterine horns. (Reproduced
from Dombroski et al.,z with permission of Mosby-Year Book, Inc.)
not only its excellent response to microbiologic chal-
lenge, but also its size and ease of manipulation.
Because of these latter attributes, direct bacterial
challenge to the genital tract has been possible using
a hysteroscope.
The rabbit is in a continuous state of estrus.
Pregnancy can be achieved readily through natural
means or through artificial insemination and ovula-
tion induction by human chorionic gonadotropin.
The gestational length is 30-31 days. The rabbit
has 2 cervices and 2 uterine horns, similar to the
human uterus didelphys. A thin vaginal septum
separates the cervices. The average litter size is 7-8
pups.
Experimental Model
Timed pregnant New Zealand white rabbits are
anesthetized with xylazine hydrochloride (5 mg/
kg) and ketamine hydrochloride (20-25 mg/kg).
After perineal and lower vaginal preparation of the
rabbit with povidone-iodine, a hysteroscope (Storz
27020B, Karl Storz Endoscopy-America, Inc.,
Culver City, CA) is introduced vaginally and ad-
vanced. The inoculum is delivered through the
operating port of the hysteroscope via a sterile poly-
ethylene cannula (0.15 cm in outer diameter) which
is prefilled and attached to a tuberculin syringe.
The bacterial inoculum may be placed in the uterus
(Fig. 1), the cervix (Fig. 2), or the vagina. Once
the inoculation is complete, the animal is returned
to the cage for observation and/o.r treatment. Each
inoculation can be completed within 3-5 min once
the operator is experienced with the technique.
Necropsy is performed after delivery or maternal
death. At necropsy, cultures may be obtained from
many sites, including the endometrium, AF, and
blood; maternal and fetal serum and AF may be
collected for study; tissues may be collected and
fixed for histology.
Organisms and Inoculation Site
Work in the rabbit model has evaluated the effect
of different microorganisms, the level of inoculum
placement in the genital tract, the natural history of
the model, and intervention with antibiotics, anti-
inflammatory agents, and passive immunization.
Dombroski et al. z inoculated the uterine horn with
Escherichia coli, Fusobacterium necrophorum, Bac-
teroides bivius, or sterile saline on day 21. High
rates of clinical, microbiological, and histological
infection were observed after bilateral intrauterine
inoculation with both E. coli and F. necrophorum
(105 cfu bilaterally). Animals inoculated with these
organisms had high rates of fever (>40C), deliv-
ery, and positive cultures of the AF. The mean
time to delivery was approximately 30 h. None of
the animals delivered live fetuses. Maternal deaths
occurred in 3/7 rabbits inoculated with F. necropho-
rum. Histology confirmed an infiltration of poly-
morphonuclear leukocytes in the endometrium, am-
nion, and chorion after inoculation with E. coll.
After inoculation with F. necrophorum, inflamma-
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Fig. 2. Schematic representation of experimental inoculation of the rabbit cervix. (Reproduced
from Heddleston et al.,s with permission of Plosby-Year Book, Inc.)
tion and necrosis were identified in the membranes
and endometrium. An additional, striking finding
was the extensive placental abruption and engorge-
ment of vascular channels within the placenta in
animals inoculated with F. necrophorum.
In contrast, only a modest rate of clinical infec-
tion occurred after inoculation, with B. bivius (105
cfu bilaterally). Although B. bivius was recovered
from the endometrium in 22/29 (79%) animals,
fever was observed in only 16% and live fetuses
were seen in 88%. A low rate of infection was seen
in control animals, largely due to contamination
with enterococci. In the absence of inadvertent con-
tamination, there was no clinical or histological
evidence of infection in saline-inoculated animals.
In our laboratory,
3 we have confirmed the find-
ings of Dombroski et al. for intrauterine inocula-
tion with both E. coli and F. necrophorum. Further,
in the absence of contamination, inoculation with
pyrogen-free saline did not result in adverse mater-
nal or fetal outcome. In all previous experiments,
live bacteria had been used with bilateral uterine
horn inoculation. We decided to test the effect of
heat-killed organisms. On day 21, 5 animals were
inoculated hysteroscopically into each uterine horn
with 0.2 ml of 105 cfu/ml of heat-killed F. necro-
phorum and observed for signs of delivery. Animals
were observed up to 7 days after inoculation. Ofthe
5 animals inoculated with heat-killed organisms, 4
were put to death on day 7. These animals did not
develop fever and did not deliver early, and all
pups were live. One animal did have a positive
culture for enterococcus in the AF and endome-
trium, but did not deliver. The fifth animal deliv-
ered 4 days after inoculation (day 25), but did not
have a fever or positive culture. We concluded that
we did not have a significant effect from the intra-
uterine inoculation of heat-killed F. necrophorum.
Since the previous experiments had all used bi-
lateral intrauterine inoculation, we tested the effect
of unilateral inoculation. We inoculated 3 animals
with live F. necrophorum in only uterine horn on
day 21. Two of the 3 delivered prior to 7 days, and
in both cases there was an associated maternal death.
The third animal had no evidence of F. necropho-
rum at the time of necropsy, and all pups were live.
From these pilot experiments, we have speculated
that the overall outcome is not changed after unilat-
eral uterine horn inoculation with F. necrophorum.
Whether the mechanism of loss with unilateral in-
oculation results from a spread of infection to the
contralateral horn or from the overwhelming ef-
fects of maternal sepsis remains unknown.
We have also performed experiments using in-
tracervical inoculation with type-Ib group B strep-
tococcus (GBS). Timed pregnant rabbits on day 21
were inoculated intracervically with 10z-106 of
type-Ib GBS. Animals were put to death after heavy
vaginal bleeding, delivery, or 6 days. Seven of 8
(88%) animals developed fever. All 8 animals de-
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livered early, and a live fetus was present in only
of the litters. All 8 animals grew GBS from the
endometrium; 5/7 (71%) from the AF; and 4/8
(50%) from maternal blood.
At the University of Texas, Field et al.
4 deter-
mined the effects of intrauterine inoculation of
Gardnerella vaginalis on maternal and fetal outcome
in the rabbit model. Animals on day 20-21 of
gestation were inoculated hysteroscopically with
104-106 cfu/ml of G. vaginalis. Animals were sac-
rificed on day 4 after inoculation, or earlier if
delivery occurred. Of 17 animals inoculated with
G. vaginalis, 3 developed fever, 2 had preterm
labor, and 80% of the pups were born live. In
addition, all 17 animals grew G. vaginalis from the
decidua, and 15/17 from the AF. Peritoneal and
blood cultures were negative in all 17 animals. In
contrast, of 14 animals in the saline-inoculated
group, none developed maternal fever, delivered
early, or had positive cultures. Although differ-
ences between the 2 groups were not significant for
most outcomes, there was a statistically significant
decrease in the live-birth rate of animals inoculated
with G. vaginalis compared with saline-inoculated
animals (80% vs. 95%). Furthermore, when brain
histology was performed, animals in the G. vagi-
nalis group had a 60% incidence of severe brain
injury compared with 0% in the saline-inoculated
group. In summary, intrauterine inoculation with
E. coli and F. necrophorum and intracervical inocu-
lation with GBS resulted in clinical, microbiologi-
cal, and histological evidence of infection. Intra-
uterine inoculation with B. bivius or G. vaginalis
resulted in lower rates of clinical infection and fetal
loss, but did result in high rates of positive cultures
in the decidua. In the absence of contamination,
saline inoculation did not result in any adverse clin-
ical outcome.
The role of inoculum size has been studied in the
rabbit model both for E. coli and GBS. Dombroski
et al.
2 evaluated the effect of inoculum size with E.
coli and found no difference in outcomes between
inocula of 103-104 and 107--108 cfu/uterine horn.
Using GBS in our laboratory, we observed high
rates of fever and delivery after bilateral intracervi-
cal inoculation with 102-106 cfu. Both of these
virulent organisms produce high rates of infection
independent of the inoculum size tested.
Because intrauterine inoculation with E. coli and
F. necrophorum resulted in rapid intrauterine infec-
tion, fetal loss, and maternal sepsis, other inoculum
sites were tested to determine the clinical course. In
particular, for intervention experiments, it would
be necessary to have a window of time prior to
fulminant infection in which to test strategies for
intervention. Direct intracervical placement offered
the advantage ofavoiding contamination ofthe ster-
ile endometrium by vaginal bacteria. When Hed-
dleston et al.
5 inoculated animals intracervically
with E. coli (0.2 ml of 105 cfu/ml), all 14 demon-
strated (ever within 24 h. Thirteen of 14 (93%)
had bleeding at 24 h. Delivery by 24 h occurred in
7/14 (50%), and there were no live fetuses seen in
any of the animals evaluated at delivery or at the
time of necropsy. In contrast, in saline-inoculated
animals, none had fever, bleeding, or delivery by
24 h. Live fetuses were found at necropsy in all
cases, and there were no positive cultures.
In additional experiments in our laboratory, 6
animals were inoculated with 105 cfu of E. coli in
the upper vagina. Two of 6 ultimately developed
clinical infection and aborted (1 mother died).
Compared with intrauterine inoculation, intracer-
vical inoculation has resulted in very similar out-
comes except for a longer interval between inocula-
tion and infection. As will be described later, this
time allowed for antibiotic administration and preg-
nancy salvage.
R f C,tkins
The natural history of this model after intracervical
inoculation with E. coli was described by McDuf-
fie et al.
6 The primary objective of this study was to
determine whether cytokines were produced in the
AF after intracervical inoculation with E. coli.
Timed pregnant rabbits on day 21 were inoculated
intracervically with 104--105 CfU of E. coli, Ani-
mals were put to death at 4, 8, 12, and 16 h after
inoculation. Six control animals were put to death
at similar intervals. Based on prior experiments,
we knew that delivery and fetal loss occurred as
early as 24 h. Therefore, we chose times in which
we could measure cytokines before these outcomes
occurred. Pooled AF was collected and assayed for
tumor necrosis factor (TNF)- bioactivity by a
modified fibroblast cytotoxlc assay using L929 cells.
In addition, interleukin (IL)- e, IL- [, pros-
taglandin E2, and prostaglandin F2 were assayed
by radioimmunoassay. Cultures-were taken from
the endometrium, AF, and blood. None of the
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control animals developed fever. None of 3 E.
coli-inoculated animals sacrificed at 4 h had fever.
Fever developed in 2/5 (40%) at 8 h, 2/3 (67%) at
12 h, and 4/5 (80%)at 16 h. Endometrial cultures
were positive in all 16 E. coli-inoculated animals.
AF cultures were positive in 1/3 animals killed at 4
h, 4/5 (80%)at 8 h, 3/3 (100%)at 12 h, and 4/5
(80%) at 16 h. Blood cultures were positive in 2/5
(40%) animals at 8 h, 3/3 (100%) at 12 h, and 4/5
(80%) at 16 h. Cultures were negative in all control
animals. The AF levels of all 3 cytokines increased
significantly with time from intracervical inocula-
tion with E. coli. Similarly, levels of AF pros-
taglandin E2 and prostaglandin F2o increased sig-
nificantly with time from inoculation with E. coli.
In these studies, we demonstrated that TNF-e,
IL-lx, and IL-I[3 are present in the AF after
intracervical inoculation with E. coli. These studies
confirm cytokine activation after microbiologic col-
onization of the decidua, since 0/6 control animals
had detectable levels. Levels of cyotkines and pros-
taglandins were detectable as early as 4 h after
intracervical inoculation and were detectable by
12-16 h after inoculation in all animals. The as-
cending nature of the model was confirmed again
because AF cultures and blood cultures were posi-
tive with increasing frequency over time after in-
tracervical inoculation.
Intervention With Antibiotics
We also sought to determine whether intervention
could improve the outcome of fulminant intra-
amniotic infection and sepsis and fetal death which
occurred uniformly after intrauterine inoculation.
First, we studied the effect of antibiotic interven-
tion after intrauterine inoculation with E. coli. Rab-
bits on day 21 or 22 were inoculated hysteroscopi-
cally with 0.2 ml of E. coli (105 cfu/ml). Animals
received either no treatment or ampicillin/
sulbactam, 100 mg/kg/day IM, in 3-4 divided
doses, beginning 1-2 h before bacterial inoculation
and continuing up to 7 days. An additional series of
animals was inoculated with E. coli and treated with
ampicillin/sulbactam immediately after inoculation
(0 h, 2 h, or 4 h after inoculation). In this series,
the dosage was increased to 150 mg/kg/day when
serum ampicillin/sulbactam levels in the initial an-
imals showed values in the low therapeutic range.
As before, animals were killed after delivery or
after 7 days. Of animals treated with ampicillin/
TABLE I. Treatment with antibiotics: Outcome by
E. coli intrauterine inoculum and time of treatment
Hours from E. coli
inoculation to treatment
b
Outcome <0 P* 4
Delivery 3/15 (20%) <0.01 8/10 (80%)
Positive culture 3/15 (20%) <0.01 6/10 (60%)
Live fetus present 15/15 (100%) <0.001 2/10 (20%)
aFrom McDuffie et al.
bAmpicillin/sulbactam.
*Fisher’s exact test.
sulbactam 1-2 h prior to inoculation, 3/11 (27%)
delivered before 7 days, 3/11 had positive cultures,
and at least live fetus was present in all 11. These
results were significant when compared with un-
treated animals, in which all 10 animals delivered
and had positive cultures and no live fetus was
present in any litter. In addition, the AF levels of
prostaglandin g
2 and prostaglandin geot were sig-
nificantly higher in untreated animals when com-
pared with treated animals. The second series of
animals, in which antibiotics were delayed for 2
and 4 h after inoculation, demonstrated that there
was a very narrow window for antibiotic adminis-
tration. As shown in Table 1, animals treated at 4 h
after intrauterine inoculation with E. coli had sig-
nificantly more deliveries, more positive cultures,
and fewer live fetuses when compared with animals
treated at or before the time of inoculation. Over-
all, there were improved outcomes in animals
treated with ampicillin/sulbactam compared with
those untreated; however, with intrauterine inocu-
lation, there was a very narrow window for im-
proving outcome.
We observed similar benefits in experiments us-
ing intrauterine inoculation with F. necrophorum.
On day 21-22, rabbits were inoculated hystero-
scopically with 104-10 s cfu of heat-killed or live
F. necrophorum. Sixteen animals were inoculated
with live F. necrophorum and randomly assigned to
ampicillin/sulbactam or saline treatment beginning
at the time of inoculation. Animals were put to
death after delivery or after 6 days. As stated previ-
ously, experiments with heat-killed organisms did
not result in significant pregnancy loss. Those rab-
bits treated with ampicillin/sulbactam had signifi-
cantly more live fetuses, fewer positive cultures,
and less fever at 24 h than those untreated (Table
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TABLE 2. Treatment with antibiotics: Outcome by intrauterine inoculum and treatment for F. necrophorum
Live
Outcome Killed Untreated P* Treated
Fever 0/5 (0%) 5/6 (83%) <0.01 0/8 (0%)
Live fetus 5/5 (100%) 0/7 (0%) <0.001 8/8 (100%)
Positive culture I/5 (20%) 7/7 (100%) <0.001 0/8 (0%)
aAmpicillin/sulbactam, 150 mg/kg/day in 4 divided doses.
*Fisher’s exact test.
2). Untreated animals had a clinical course of rap-
idly developing intraamniotic infection and mater-
nal sepsis. Vaginal bleeding was observed in all 7
saline-treated animals by 24 h and in 0/8 antibiotic-
treated animals.
Intervention With Antibiotics and Indomethacin
Because of the short window of opportunity for
treatment after intrauterine inoculation of E. coli,
Heddleston et al.
5 conducted experiments with
intracervical inoculation and delayed ampicillin/
sulbactam therapy at 0, 4, 8, 12, and 16 h after
inoculation with E. coli. Animals inoculated intra-
cervically wi-th E. coli and receiving delayed antibi-
otic therapy demonstrated gradually decreasing rates
of fetal survival (Fig. 3). Animals inoculated in-
tracervically that had antibiotics begun at 16 h had
similar outcomes to animals inoculated with E. coli
that were untreated. In an additional arm of this
work, indomethacin pretreatment (0.2 mg/kg IV)
was given to rabbits receiving no antibiotic ther-
apy. In E. coli-inoculated animals receiving no an-
tibiotic therapy, pretreatment with indomethacin
significantly decreased bleeding and delivery within
the first 24 h compared with those not pretreated,
but did not improve overall fetal survival.
Intervention With Type-Specific Antibody
In addition to antibiotic and anti-inflammatory in-
tervention, the rabbit model had the potential for
testing immunotherapy for prevention of experi-
mental infection. Previous experiments by Larsen
et al.
7 had suggested that passive immunization
with modified immune serum globulin protected
against rapid neonatal death in a monkey model.
We have conducted preliminary experiments with
passive immunization to type-Ib GBS in the rabbit.
Twenty-four hours prior to inoculation, passive
immunization with a polyclonal antibody to type-Ib
GBS capsule polysaccharide (prepared in rabbits)
was given in a dosage calculated to achieve a mini-
mum of 2 pog/ml, which had been shown to be
protective in other models. Rabbits on day 21 were
inoculated intracervically with 102--106 cfu of
type-Ib GBS. Animals were put to death after heavy
vaginal bleeding, delivery, or after 6 days. As seen
in Table 3, there were no differences between
treated and untreated groups in outcomes of fever,
delivery, or presence of a live fetus. An assay for
type-specific antibody concentration in maternal and
fetal serum was not available.
Summary
The rabbit model demonstrates rapid, reproducible
intrauterine infection accompanied by maternal sep-
sis after inoculation. The most reproducible routes
of inoculation are the direct placement into the
endometrium or the cervix. There is evidence that
high vaginal inoculation will produce modest rates
of infection. For E. coli, F. necrophorum, and GBS,
this infection appears to be an "all-or-none" phe-
nomenon in that, once infection occurs, there is
rapid progress to fulminant intraamniotic infection
and sepsis. Intervention with antibiotics is effective
within 0-2 h for intrauterine infection and up to 12
h after intracervical inoculation. Indomethacin pre-
treatment decreased fever in some treated animals,
but did not result in improved clinical outcome.
Limited experiments with passive immunization
did not improve outcome. Other potential inter-
ventions with the model include comparative ef-
fects of antibiotics, use of cytokine modulators and
blockers, and further work with immunotherapy.
MONKEY MODEL
Primate models offer the desirable features of sin-
gleton gestation and uterine anatomy which are com-
parable to humans. Further, the placentation is
hemochorial as in humans. The gestational length
is approximately 160 days.
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Fig. 3. Fetal rabbit survival by delay in initiating antibiotic therapy after intracervical inoculation.
*Fisher’s exact test compared with E. coli and no therapy; NS not significant. (Reproduced from
Heddleston et al.,s with permission of Mosby-Year Book, Inc.)
TABLE 3. Treatment with type-specific antibody:
Outcome by treatment group (intracervical
inoculation of type-lb GBS)
Untreated Treated
Outcome (N 8) P* (N II)
Fever 7/8 (88%) NS 8/11 (73%)
Delivery 8/8 (100%) NS 9/11 (82%)
Live fetus I/8 (12%) NS 3/11 (27%)
aType-specific antibody.
*Fisher’s exact test; NS not significant.
Experimental Model
Timed pregnant rhesus monkeys (Macaca mulatta)
undergo intraamniotic inoculation using percutane-
ous amniocentesis approximately 24 h prior to de-
livery (160 days). A 3.81-cm, 22-gauge needle is
inserted through the abdominal wall in the midline
above the umbilicus and then angled toward the
pelvis in order to penetrate the uterus fundoceph-
alad, since the usual attachment of the placenta is
anterior. After placement is confirmed by checking
for free aspiration of" AF, a bacterial inoculum
grown to logarithmic phase and diluted to the de-
sired concentration is injected. Gross mixing of
fluid and bacteria is performed by aspirating 5 ml
of fluid and reinjecting the fluid 5 times. The
animal is then returned to the cage for observation
and/or treatment.
Experimental Work
Larsen et al.
8 inoculated 10 rhesus monkeys in-
traamniotically near term with 0.5 ml of 10s-2
10
7 cfu/ml of type-Ic or type-iiI GBS. No treat-
ment was given in the initial series. Approximately
24 h after inoculation, the animals were delivered
by cesarean section. Cultures were obtained from
AF and cord blood at the time of cesarean section.
In the neonate, peripheral blood cultures and spinal
fluid were obtained 3 h after birth. At 24 and 48 h
after birth, blood and cerebrospinal fluid cultures
were taken from surviving neonates. Monkeys that
died underwent prompt necropsy. Ofanimals inoc-
ulated with type-Ic GBS, 1/5 (20%) neonates died.
Of animals inoculated with type-III GBS, 4/5
(80%) neonates died. GBS was consistently isolated
from the AF, throat, and rectum in newborn mon-
keys. Nine of the 10 newborn monkeys had posi-
tive cord blood for GBS. Of the 5 animals that
died, was stillborn and the other 4 died between
25 and 96 h after inoculation (24 h prior to deliv-
ery). Spinal fluid cultures performed at 24 and 48
h of life were negative in survivors. Positive spinal
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fluid cultures occurred antemortum in the 2 mon-
keys that died at 96 h after inoculation. Viable
colony counts in the AF reached l0
9 cfu/ml at 24 h
following inoculation. Necropsy showed pneumoni-
tis in the 5 and meningitis in the 2 monkeys that
survived for 96 h after inoculation. Since pneumo-
nia was present in all monkeys that died after in-
traamniotic inoculation, aspiration of infected AF
was likely an important factor in the development
of disease. It was noted that fetal bacteremia, as
manifested by positive cord blood culture, did not
always predict outcome.
In an intervention trial, Larsen et al.
9 continued
their work using antibiotic intervention immedi-
ately after intraamniotic inoculation. Nineteen preg-
nant rhesus monkeys at term were inoculated amni-
otically with approximately 106 cftl of type-III
GBS. Based on their previous work, type-III GBS
was felt to be the more virulent organism. Inocula-
tion occurred 24 h prior to cesarean delivery. Ani-
mals were treated with penicillin G, 20,000 U/kg
IV, plus procaine penicillin G, 10,000 U/kg IM.
Six of 10 untreated neonates died, while only 1/9
penicillin G-treated neonates died (P 0.04) after
intraamniotic inoculation with type-III GBS. Pneu-
monitis was discovered at autopsy in all neonates
that died. In addition, 4/6 dead neonates in the
untreated group had histologic evidence of menin-
gitis. The neonate that died in the penicillin group
had evidence of pneumonitis, but there was no
meningitis; cultures were negative for type-III
GBS. In the untreated control group, 7/10 (70%)
neonates had positive cord blood cultures, 10/10
(100%) had positive throat cultures, and 3/10
(30%) had positive spinal fluid cultures. In the
penicillin G-treated group, no neonate had a posi-
tive cord blood or spinal fluid culture. Three of 10
neonates in the treated group had a positive throat
culture.
In further work, Larsen et al.
7 studied the rela-
tionship between susceptibility to intraamniotic in-
fection with type-III GBS and concentration oftype-
specific antibody in serum of mothers and
offspring. In 17 animals inoculated intraamnioti-
cally (controls), there was a significant association
between the concentration of maternal antibody
prior to infection and both the neonatal survival
rate and survival time. In an intervention trial,
modified immune serum globulin was given IV to
10 mothers prior to intraamniotic infection. Then,
in their neonates, 5 animals received neonatal mod-
ified immune serum globulin and 5 did not. Al-
though neither of the modified immune serum
globulin groups demonstrated a reduction in neo-
natal mortality compared with controls, the authors
concluded that this therapy provided protection
against rapid neonatal death among those animals
born to mothers with low antibody to type-III GBS
prior to immunotherapy. As before, 106 cfu of
type-III GBS was inoculated intraamniotically 24 h
prior to delivery. The concentration of antibodies
of native polysaccharide antigen of type-III GBS
was quantitated in sera by radioactive antigen-bind-
ing assay. Maternal sera were collected prior to
administration of modified immune serum globu-
lin and 24 h after administration. Neonatal sera
were collected at birth. Modified immune serum
globulin was given to mothers as an IV infusion of
5 ml/kg (250 mg/ml) over a 1-h period 24 h prior
to intraamniotic infection. Neonates who received
immune serum globulin received an IV injection of
5ml/kg in the umbilical vein over 3 min immedi-
ately after birth. In the control group, 12/17 (71%)
neonates died. Levels of antibody to type-III GBS
were lower in the preinoculation sera of mothers
whose neonates died than of mothers of survivors.
In the 2 groups treated with modified immune
serum globulin, 3/5 (60%) neonates died in each
group. This rate was not different from the rate of
control animals. Antibody concentrations in the 22
paired maternal sera and cord sera were compared.
A significant correlation was seen between antibody
concentrations in maternal sera collected prior to
delivery and matched neonatal cord sera, which
indicated antibody transfer in most instances. In
this study, in untreated animals, a statistically sig-
nificant relationship between the concentration of
maternal antibody and neonatal survival was dem-
onstrated.
Ten years later, Gravett et al.
10 used the monkey
model to establish a relationship between AF infec-
tion, cytokines, prostaglandins, and uterine activ-
ity. In 3 chronically instrumented rhesus monkeys
at day 130 of gestation, AF infection was estab-
lished by intraamniotic inoculation of 106 cfu of
type-IIi GBS. in this chronically instrumented
model, maternal blood, fetal blood, and AF were
sampled sequentially. Increases in uterine contrac-
tility occurred between 14 and 36 h after inocula-
tion in all 3 monkeys and led to progressive cervical
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dilation in 2/3 monkeys. Sequential sampling of
AF for bacteria, IL-113, and prostaglandins re-
vealed increases in bacterial count from a preinocu-
lation rate of 0 to 10
9 cfu/ml at delivery and in-
creases in AF IL-l[3, prostaglandin g2, and
prostaglandin Feot over time from inoculation. Fur-
ther, it was felt that increases in cytokines and
prostaglandins began prior to increases in contrac-
tility.
MOUSE MODEL
The mouse offers another model for infection in
pregnancy, with a short gestational length (19-21
days) and low cost. However, experimental manip-
ulation, such as direct intrauterine or intracervical
inoculation, amniocentesis, or chronic catheteriza-
tion, is more difficult. Nevertheless, the mouse has
been the subject of many reports and historically
preceded other animal models for infection in preg-
nancy. The majority of these studies did not strictly
study ascending infection, but rather used bacterial
products (endotoxin) or cytokines to induce pre-
term labor, pregnancy loss, and occasionally mater-
nal death.
In 1943, Zahl and Bjerknes
11 studied the effects
of gram-negative endotoxin in a pregnant mouse
model. They injected 150 mice intraperitoneally
with Shigella endotoxin at 12, 15, and 18 days of
gestation. By 8 h after injection, nearly all animals
experienced bleeding. No living fetuses were born
from any of the mothers. The predominant mode
of pregnancy loss was hemorrhage and abruption,
which led either to labor and expulsion of the em-
bryos or to fetal resorption. Takeda and Tsuchiya
12
prepared an endotoxin from E. coli that was in-
jected IV into pregnant mice before 20 days of
gestation. These animals were then observed for 24
h. In all cases, the animals aborted and fetal death
occurred. In addition, the maternal death rate was
75%. More recently, Gendron et al.
13 examined
the phenomenon of lipopolysaccharide-induced fe-
tal resorption in mice because Zahl and Bjerknes
11
had demonstrated that bacterial endoxotins induced
fetal resorption (in addition to causing abortion).
IV administration of 25 pg of lipopolysaccharide
on day 12 resulted in the appearance of TNF-Ot in
the AF and fetal resorption. In addition, they per-
formed intervention studies using pentoxifylline, a
drug known to suppress formation ofTNF-ot. They
demonstrated that levels of lipopolysaccharide-in-
duced TNF-Ot were reduced by 90% after pretreat-
ment and concluded that TNF-Ot is involved in
lipopolysaccharide-induced fetal resorption in mice.
In other recent studies, Romero et al.
14 studied
the role of IL-1 in preterm parturition in mice to
determine whether systemic administration of IL-1
could induce parturition in mice. Twenty-four mice
were randomized to receive human recombinant
IL-lot or sterile phosphate-buffered saline subcuta-
neously at 15-17 days of gestation. Injections were
performed using p,g of IL-lot diluted in 100 p,1
of phosphate-buffered saline. Three injections were
given over 5.5 h. No animals receiving phosphate-
buffered saline exhibited vaginal bleeding. In IL-
o t-treated animals, vaginal bleeding was noted as
early as 2 h after the second injection and by 12 h
after commencement of the protocol. Ten of 12
(83%) animals had vaginal bleeding. Preterm de-
livery occurred in 11 IL-lot-treated animals (1
animal died). All animals in the control group de-
livered at 20 days or later. Live fetuses were seen in
all 12 control animals.
In later experiments, Romero and Tartakovsky
is
determined whether pretreatment with the IL-1
receptor antagonist could prevent preterm parturi-
tion induced by IL-lot. Animals were randomly
allocated to an initial set of experiments in which
the authors determined the dose of IL-1 that would
reliably induce preterm delivery after subcutaneous
administration. In the second phase, animals were
treated with human recombinant IL-1 and increas-
ing dosages of IL-1 receptor antagonist. They did
demonstrate that a combination ofhuman recombi-
nant IL- (10 p,g) and IL- receptor antagonist (1
mg) administered subcutaneously did not result in
premature delivery in 12 pregnant mice. Using a
similar dose of IL- 1, lower dosages of IL- recep-
tor antagonist (0.25 and 0.5 mg) were associated
with increased rates of premature delivery (100%
and 66.6%, respectively).
In summary, studies on the mouse have pro-
vided insight regarding the systemic administra-
tion of bacterial products, cytokines, and cytokine
blockers. In this paradigm, systemic administra-
tion results in a local effect on the uterus, preterm
labor. In contrast, ascending infection causes re-
lease of cytokines and prostaglandins within the
uterus and intrauterine infection prior to systemic
spread of disease. Therefore, it is uncertain whether
the mouse model, which uses systemic administra-
68 INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGYMODELS OF ASCENDING INFECTION McDUFFIE AND GIBBS
tion to achieve effect, truly mimics ascending infec-
tion in pregnancy.
DISCUSSION
Each of these 3 models offers different observations
on infection in pregnancy. It is important now to
compare and contrast these models with respect to
several issues. First and foremost, the model must
mimic the pathogenesis in humans. Second, the
model must be reproducible. Further, it is impor-
tant to discuss the applicability of the animal model
to the human state. Other important issues include
cost, anatomy, and pharmacokinetics.
Ascending infection is accepted as the mode of
bacterial entry to the uterus in cases of intraamni-
otic infection. There is strong circumstantial evi-
dence that subclinical infection is linked to prema-
ture birth. In the models presented, only the rabbit
model mimics natural ascending infection in preg-
nancy. By hysteroscopic placement, a variety of
organisms can be directly placed into the uterus,
cervix, or vagina. The level of placement directly
correlates with the reproducibility of infection.
With E. coli or GBS, nearly 100% of animals
inoculated in either the uterus or cervix develop
clinical infection. However, when the inoculum is
placed in the upper vagina, a lower percentage of
animals develop clinical disease. Generally, the or-
ganism placed is the organism subsequently recov-
ered with clinical infection. The exception to this is
the occasional enterococcal infection seen with in-
trauterine inoculation. In our laboratory, the en-
terococcus is cultured as normal flora from the
rabbit vagina. Work in the monkey model bypasses
the cervix and upper vagina via direct bacterial
placement in the amniotic cavity. This step pro-
vides certainty that the bacterial inoculum will be
placed where fetal effect can occur. The ascending
nature of the rabbit work is further confirmed by
increasing rates of positive cultures over time, in-
cluding AF and maternal blood cultures in the
natural history data.
An additional piece of evidence for ascending
infection came from experiments in which antibi-
otic intervention occurred 0-4 h after intrauterine
inoculation with E. coli. In this experiment, in the
cases where live animals were found after antibiotic
treatment, they were always found in the distal
horns, suggesting that the antibiotic had had effect
prior to bacteria ascending to the distal horns. In
contrast, the mouse model did not use live bacteria
and instead focused on bacterial products and cy-
tokines which, when administered systemically, led
to fetal death and/or abortion.
The disease state produced in the rabbit is that of
intraamniotic infection leading to maternal sepsis.
In the monkey model, neonatal pneumonitis, men-
ingitis, and sepsis are documented. While the dis-
ease states produced are important when applied to
humans, it is disappointing that a model more rem-
iniscent of subclinical infection and preterm labor
has not been produced. The work by Field et al.
4
demonstrates that a chronic intrauterine infection
with G. vaginalis can be established, but the rate of
preterm labor is not increased significantly over the
rate of saline-inoculated animals. Perhaps trials with
other organisms may produce different results.
We are able to show that antibiotic intervention
after intrauterine and intracervical inoculation re-
sults in improved clinical outcome, although there
is a very narrow window of time in which it occurs.
As in intraamniotic infection in humans, levels of
prostaglandins and cytokines are elevated after bac-
terial infection. This is confirmed in both the rab-
bit and monkey models. Because of technical con-
siderations, it is necessary to pool AF in the rabbit
model in order to obtain enough for several assays.
In the monkey, there is a greater amount of AF
present. This potentially could be harvested by both
repeated aminocenteses or chronic catheterization,
as done by Gravett et al.
10 The advantage of this
latter technique allows for serial sampling within a
given individual. It is more difficult in small ani-
mals to achieve the technology necessary to sample
serially.
Clearly, the underlying physiology favors the
monkey model because of its comparability to hu-
mans. Both uterine anatomy and litter size are
markedly different for both the rabbit and the
mouse. In addition, maternal pharmacokinetics and
the pharmacokinetics of placental transfer may be
markedly different from species to species. The
cost factor obviously favors a less-expensive model
with a shorter gestation, as in the rabbit and mouse
models. Nevertheless, the work in the monkey is
critical to the validity of other work obtained from
less-costly models.
In this review, we have discussed the current
animal models of ascending infection in pregnancy.
The primary advantages of the rabbit model are its
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ascending nature, reproducibility, low cost, and
applicability to the human situation. The advan-
tages of the monkey model are its close relation to
humans and the size of the animal, which allows for
serial sampling and improved neonatal informa-
tion. The disadvantages of the monkey model in-
clude its cost and long gestation. The mouse model
is the least costly of the models. The effects of
parenteral administration of bacterial products and
cytokines in the mouse mimic the end stage of
ascending infection in which there is a systemic
maternal response. Nevertheless, the administra-
tion of cytokines has produced preterm parturition
in mice. The role of true ascending infection in this
model remains unexplored. These models all shed
light on the evolving picture of infection as a cause
of preterm birth. Future studies will continue to
elucidate mechanisms of preterm labor associated
with infection in these animal models.
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